Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barenfanger, J. Articles by Drake, C. Search for Related Content PubMed PubMed Citation Articles by Barenfanger, J. Articles by Drake, C.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2004, p. 236-238, Vol. 42, No. 1
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.1.236-238.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Nonvalue of Culturing Cerebrospinal Fluid for Fungi

Joan Barenfanger,^* Jerry Lawhorn, and Cheryl Drake

Memorial Medical Center, Springfield, Illinois

Received 31 July 2003/ Returned for modification 20 September 2003/ Accepted 11 October 2003

Top Abstract Introduction Materials and Methods Results Discussion References

 
No studies have evaluated the efficacy of culturing cerebrospinal fluid (CSF) for fungi. Because of the facts that the most common fungi responsible for meningitis grow well in media utilized for routine bacterial cultures and that cryptococcal antigen tests are commonly ordered, the efficacy of routinely performing fungal cultures specifically to recover fungi has been questioned. We examined data from 1,225 samples of CSF which were cultured for both bacteria and fungi. Twelve specimens yielded fungi, 10 from fungal cultures and 8 from bacterial cultures. Cryptococcus neoformans was found in 10 specimens, Candida albicans was found in 1, and a Cladosporium sp. was found in 1. Eight of 12 positive specimens had concordant culture results. The discordant cases were one specimen that was bacterial culture positive but fungal culture negative and three specimens that were fungal culture positive but bacterial culture negative. Of the latter discrepant cultures, one had fungal contamination only and the other two were positive for cryptococcal antigen. Therefore, omitting the fungal cultures on these specimens would not adversely impact patients. When both cryptococcal antigen tests and bacterial cultures are ordered routinely, eliminating fungal cultures on CSF would have had no impact on the patients in this study. All the clinically significant fungi were detected by the cryptococcal antigen test and/or bacterial culture. With a few exceptions, the combined use of cryptococcal antigen test and bacterial cultures of CSF could replace routine fungal cultures of CSF. Exceptions include settings where fungal pathogens other than Cryptococcus and Candida remain important causes of meningitis.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Although studies have addressed the efficacy of performing mycobacterial cultures on cerebrospinal fluid (CSF), no studies have evaluated the efficacy of culturing CSF for fungi (1). Some laboratories may actually use criteria similar to those established for the rejection of mycobacterial cultures to reject cultures on CSF for fungi, but actual data to provide evidence for this process are lacking (5; K. Bromberg, Letter, Lancet i:1023, 1980). Because of the facts that (i) Cryptococcus and Candida spp. (by far the most common fungi responsible for meningitis) grow well in media utilized for routine bacterial cultures and that (ii) cryptococcal antigen tests are commonly ordered, the efficacy of routinely performing fungal cultures specifically to recover fungi on CSF has been questioned. In addition, the onus is now on clinical microbiology laboratories to practice evidence-based medicine, which includes concepts of evaluating tests to ensure that they yield clinically useful results. To determine the clinical utility of routinely performing fungal cultures specifically to recover fungi on CSF, we performed the present study.

(This work was presented in part at the 103rd General Meeting at the American Society for Microbiology, Washington, D.C. [G. Lawhorn, J. Barenfanger, and C. A. Drake, Abstr. 103rd Gen. Meet. Am. Soc. Microbiol., abstr. C-096, p 135, 2003].)

Top Abstract Introduction Materials and Methods Results Discussion References

 
A retrospective study of data from 1 January 1994 to 1 July 2002 was conducted at Memorial Medical Center, a 450-bed community teaching hospital in Springfield, Ill. Although this hospital has a burn unit, a transplant service, and a regional cancer center, the vast majority of its patients are from the immediate community in central Illinois. Its pediatric population (<18 years of age) is less than 5% of all patients.

Samples of CSF which were cultured for both bacteria and fungi were examined. In addition, if a fungal pathogen were detected by the antigen test for Cryptococcus, then these data were included. Medical charts for all patients who had cultures positive for fungi were reviewed.

Cultures were performed by current standard accepted procedures. For bacterial cultures, CSF was spun for 15 min at 3,000 x g and the sediment was inoculated onto sheep blood agar plates and chocolate agar plates and was inoculated into thioglycolate broth. These cultures were incubated at 37°C and examined daily for 3 days. For fungal cultures, the CSF sediment was inoculated onto Sabouraud 4% dextrose agar plates and sheep blood agar plates, incubated at 30°C, and examined weekly for 4 weeks. Any microorganism grown on either the fungal or bacterial culture was worked up as a potential pathogen. Standard techniques were used for yeasts and fungi, including those for determination of growth rate and colony morphology, lacto-aniline blue staining of colonies, and determination of the biochemical profile by Vitek 2 (bioMerieux, Durham, N.C.).

If requested, a latex agglutination antigen test for Cryptococcus (Meridian Bioscience Inc., Cincinnati, Ohio) was performed on the CSF, generally within 24 h of its receipt in the laboratory.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Of 1,225 samples of CSF reviewed, 12 tested positive for fungi, either by bacterial culture, fungal culture, or the cryptococcal antigen test. Of cultures from these 12 samples, 10 fungal cultures were positive and 8 bacterial cultures were positive. Cryptococcus neoformans was found in 10 of the specimens, Candida albicans was found in 1, and a Cladosporium sp. was found in 1. Eight of the 12 positive specimens had concordant results for each culture method, including 1 specimen which was negative by both fungal and bacterial culture but cryptococcal antigen positive (Table 1). The discordant cases were as follows: (i) on one specimen, the bacterial culture was positive for Cryptococcus (as was the antigen test) but the fungal culture was negative and (ii) on three specimens, the fungal cultures were positive (two for Cryptococcus and one for Cladosporium spp.) but the bacterial cultures were negative (Table 1). The two specimens which grew Cryptococcus on the fungal culture only were also positive for Cryptococcus by the antigen test.

View this table: [in this window] [in a new window]

TABLE 1. Specimens of CSF analyzed for fungi by both bacterial and fungal cultures

The patient who had the fungal culture positive for the Cladosporium sp. was thought not to have fungal meningitis and was not treated for this. This isolate was considered clinically to be a contaminant.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Cryptococcus is by far the most common fungus responsible for meningitis, followed by Candida spp. as a distant second, except in pediatric patients, where Candida spp. account for the vast majority of infections (3, 7). Our study has shown that, in the population studied, the combined use of the antigen test for Cryptococcus and bacterial cultures of CSF could replace routine fungal cultures of CSF. Exceptions to this policy would be in settings or clinical practices where fungal pathogens other than Cryptococcus and Candida remain important causes of meningitis, such as areas where Coccidioides spp. are endemic. However, even in these regions, fungal cultures rarely yield Coccidioides from CSF (D. Pappagianis [University of California, Davis], personal communication; M. Saubolle [Department of Clinical Pathology, Good Samaritan Medical Center, Phoenix, Ariz.], personal communication). One source indicates that the culture is positive in only one-third of the cases (8). In fact, even culturing a large volume (10 ml) of CSF recovers the fungus in only approximately one-half the cases of confirmed meningitis due to Coccidioides (D. Pappagianis, personal communication). Another source indicates that the best way to make a diagnosis of meningitis due to Coccidioides is by special communication between the laboratory and the physician and the use of repeated cultures of large volumes of CSF (2). Generally, it is acknowledged that the test of choice to diagnose meningitis due to Coccidioides is serology done on the serum and/or CSF (2, 8; D. Pappagianis, personal communication; M. Saubolle, personal communication).

Although this study was performed in an area of endemicity for histoplasmosis, none of the samples of CSF cultured for fungi grew Histoplasma capsulatum. In fact, in our collective memory (spanning >25 years here), we cannot remember any CSF which grew H. capsulatum. Meningitis due to H. capsulatum is a rare complication of histoplasmosis, but, when it occurs, it is as a chronic meningitis, not an acute meningitis (4, 9). Patients may present to their physicians weeks to many months after the onset of symptoms. CSF is positive for the fungus in only 27 to 65% of the cases. The detection of meningitis due to H. capsulatum may be better addressed by consultation with the ordering physician rather than routinely culturing all CSF specimens for fungi. Detection of serum and CSF antibodies against the fungus is the most sensitive test for histoplasmosis (4).

If patients reside in an area of endemicity for other fungal pathogens, such as Blastomyces dermatitidis, then this issue should be examined by using the local data (evaluating the yield of clinically useful information, as was done in this study). A feature in B. dermatitidis infections useful for differentiation is that the lesions are usually focal in the CNS, as opposed to the more-diffuse meningitis caused by other fungi (4).

Other exceptions or potential problems with routinely eliminating fungal cultures on CSF might include situations where the patients have immunodeficiences or are immunosuppressed (such as treatment centers for human immunodeficiency virus patients or cancer centers). Another pertinent issue may be the distinction between acute meningitis and chronic meningitis, which this study did not address. The diagnosis of chronic meningitis should be seriously considered if the neurologic findings persist or progress and the CSF remains abnormal for at least 4 weeks (4). Fungal cultures are considered mandatory in chronic meningitis (4). Unfortunately, the test requisitions which most clinical microbiology laboratories receive currently do not indicate whether acute or chronic meningitis is suspected. It is remotely possible that, with the newer requirements for test requisitions, this information will be available in the future.

Practice guidelines for the management of cryptococcal disease indicate that fungal cultures should be done, but they did not specify which type of media would suffice to detect Cryptococcus (6). In addition, the use of the antigen test for C. neoformans is indicated by the guidelines.

Of the 12 patients in this study positive for fungi, 1 was positive only by the cryptococcal antigen test, 10 were positive by fungal culture, and 8 were positive by bacterial culture. All specimens which grew Cryptococcus in cultures for either fungi or bacteria were positive for Cryptococcus by the antigen test. If no fungal cultures had been done on these specimens, three potentially positive specimens may have been missed by performing only bacterial cultures. However, one of these three specimens was considered a contaminant (Cladosporium sp.), and the other two had positive cryptococcal antigen tests. Therefore, omitting the fungal cultures on these three specimens would have had no adverse clinical impact on these patients. If the cost of performing fungal cultures is $70, then, in the last 8.5 years, the cost avoidance of eliminating fungal cultures of CSF in this setting would have been over $85,000 ($70 x 1,225 cultures) or over $10,000 annually.

If antigen tests for Cryptococcus are not done routinely, then the use of fungal cultures is still justified since this study indicates that there is a 30% likelihood that using bacterial cultures alone will result in a missed diagnosis of meningitis due to Cryptococcus. Before routinely eliminating fungal cultures on CSF, an educational program should be conducted by appropriate people in the institution, including the microbiology personnel, to require the antigen test for Cryptococcus when bacterial cultures are ordered on CSF. In summary, when both cryptococcal antigen tests and bacterial cultures are ordered routinely, the elimination of fungal cultures on CSF would have had no impact on patients in this study. All the clinically significant fungi were detected by the cryptococcal antigen test and/or bacterial culture. This study suggests that, in areas where Candida and Cryptococcus cause the vast majority of fungal meningitis, the combined use of cryptococcal antigen test and bacterial cultures of CSF could replace routine fungal cultures of CSF. However, before any widespread conclusions or recommendations can be made from this study, other studies should be done to validate these findings.

 
* Corresponding author. Mailing address: Laboratory Medicine, Memorial Medical Center, 701 N. First St., Springfield, IL 62781. Phone: (217) 788-3000. Fax: (217) 788-5577. E-mail: barenfanger.joan{at}mhsil.com.

Top Abstract Introduction Materials and Methods Results Discussion References

 

1
1. Albright, R. E., Jr., R. H. Christenson, R. L. Habig, T. P. Mears, and K. A. Schneider,. 1998. Cerebrospinal fluid TRAP. A method to improve CSF laboratory efficiency. Am. J. Clin. Pathol. 90:707-710.
2
2. Ampel, N. 2000. Coccidioidomycosis, p. 59-77. In G. A. Sarosi and S. F. Davies (ed.), Fungal diseases of the lung, 3rd ed. Lippincott, Williams and Wilkins, New York, N.Y.
3
3. Arisoy, E. E., A. E. Arisoy, and W. Dunne, Jr. 1994. Clinical significance of fungi isolated from cerebrospinal fluid in children. Pediatr. Infect. Dis. J. 13:128-133.[Medline]
4
4. Gripshover, B., and J. Ellner. 2000. Chronic meningitis, p. 997-1009. In G. Mandell, J. Bonnett, and R. Dolin (ed.), Principles and practices of infectious diseases, 5th ed. Churchill Livingston Co., Philadelphia, Pa.
5
5. Morris, A. J., L. K. Smith, S. Mirrett, and L. B. Reller. 1996. Cost and time savings following introduction of rejection criteria for clinical specimens. J. Clin. Microbiol. 34:355-357.[Abstract]
6
6. Saag, M. S., R. J. Graybill, R. A. Lawson, P. Pappas, J. R. Perfect, W. G. Powderly, J. D. Sobel, and W. E. Dismukes. 1999. Practice guidelines for the management of cryptococcal disease. Clin. Infect. Dis. 30:710-718.
7
7. Sturgis, C. D., L. R. Peterson, and J. R. Warren. 1997. Cerebrospinal fluid broth culture isolates: their significance for antibiotic treatment. Am. J. Clin. Pathol. 108:217-221.[Medline]
8
8. Thompson R. B., and H. Bertram. 2001. Laboratory diagnosis of CNS infections. Infect. Dis. Clin. N. Am. 15:1047-1071.[CrossRef][Medline]
9
9. Tunkel, A. R., and W. M. Scheld. 2000. Acute meningitis, p. 959-997. In G. Mandell, J. Bonnett, and R. Dolin (ed.), Principles and practices of infectious diseases, 5th ed. Churchill Livingston Co., Philadelphia, Pa.

---

Journal of Clinical Microbiology, January 2004, p. 236-238, Vol. 42, No. 1
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.1.236-238.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Petraitiene, R., Petraitis, V., Hope, W. W., Mickiene, D., Kelaher, A. M., Murray, H. A., Mya-San, C., Hughes, J. E., Cotton, M. P., Bacher, J., Walsh, T. J. (2008). Cerebrospinal Fluid and Plasma (1->3)-{beta}-D-Glucan as Surrogate Markers for Detection and Monitoring of Therapeutic Response in Experimental Hematogenous Candida Meningoencephalitis. Antimicrob. Agents Chemother. 52: 4121-4129 [Abstract] [Full Text]  
• Pitisuttithum, P., Negroni, R., Graybill, J. R., Bustamante, B., Pappas, P., Chapman, S., Hare, R. S., Hardalo, C. J. (2005). Activity of posaconazole in the treatment of central nervous system fungal infections. J Antimicrob Chemother 56: 745-755 [Abstract] [Full Text]  
• McFadden, D. C., Zaragoza, O., Casadevall, A. (2004). Immunoreactivity of Cryptococcal Antigen Is Not Stable under Prolonged Incubations in Human Serum. J. Clin. Microbiol. 42: 2786-2788 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barenfanger, J. Articles by Drake, C. Search for Related Content PubMed PubMed Citation Articles by Barenfanger, J. Articles by Drake, C.